LifePlan Financial’s iShares iBonds Dec 2027 Term Corporate ETF IBDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.91M Buy
120,053
+2,929
+3% +$70.9K 2.04% 7
2026
Q1
$2.84M Buy
117,124
+7,205
+7% +$175K 2.1% 10
2025
Q4
$2.67M Buy
109,919
+1,064
+1% +$25.9K 2.05% 10
2025
Q3
$2.65M Buy
108,855
+2,127
+2% +$51.6K 2.1% 10
2025
Q2
$2.59M Sell
106,728
-1,133
-1% -$27.3K 2.15% 10
2025
Q1
$2.61M Buy
107,861
+3,380
+3% +$81.3K 2.27% 9
2024
Q4
$2.5M Buy
104,481
+1,757
+2% +$42.3K 2.21% 8
2024
Q3
$2.5M Buy
102,724
+1,770
+2% +$42.7K 2.15% 10
2024
Q2
$2.4M Buy
100,954
+2,030
+2% +$48K 2.21% 10
2024
Q1
$2.35M Buy
98,924
+3,467
+4% +$82.5K 2.16% 9
2023
Q4
$2.28M Buy
+95,457
New +$2.23M 2.29% 9

Other funds holding IBDS

LifePlan Financial's IBDS Position: Q2 2026 in Review

LifePlan Financial increased its iShares iBonds Dec 2027 Term Corporate ETF (IBDS) stake by 2.5% in Q2 2026, buying an estimated $70.9K and bringing the position to 120,053 shares worth $2.91M. The position accounts for 2.04% of the portfolio, ranked #7.

LifePlan Financial first reported a position in IBDS in Q4 2023 and has held it in 11 quarters since. 264 funds tracked by Wall St. Rank hold IBDS as of Q2 2026.

  • LifePlan Financial held 120,053 shares of iShares iBonds Dec 2027 Term Corporate ETF worth $2.91M as of Q2 2026.
  • LifePlan Financial bought 2,929 iShares iBonds Dec 2027 Term Corporate ETF shares in Q2 2026, an estimated $70.9K.
  • iShares iBonds Dec 2027 Term Corporate ETF made up 2.04% of LifePlan Financial's portfolio in Q2 2026, its #7 holding.
  • LifePlan Financial first reported a position in iShares iBonds Dec 2027 Term Corporate ETF in Q4 2023 and has held it in 11 quarters since.
  • 264 funds tracked by Wall St. Rank held iShares iBonds Dec 2027 Term Corporate ETF as of Q2 2026.

Based on LifePlan Financial's 13F filing for Q2 2026, filed 21 Jul 2026.